Drug makers McNeil-PPC and Johnson & Johnson are arguing in federal court that plaintiffs alleging injuries from over-the-counter Tylenol should not be able to depose a corporate designee on Tylenol-brand marketing expenditures, public relations and market research.
February 10, 2014 at 06:40 PM
1 minute read
Drug makers McNeil-PPC and Johnson & Johnson are arguing in federal court that plaintiffs alleging injuries from over-the-counter Tylenol should not be able to depose a corporate designee on Tylenol-brand marketing expenditures, public relations and market research.
Discovery is sought over a 44-year-old time period.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
